Eli Lilly And reported $5.47B in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US USD 8.76B 123M
Abbvie ABBV:US USD 10.21B 1.08B
Amgen AMGN:US USD 4.61B 695M
Astrazeneca AZN:US USD 9.74B 495M
AstraZeneca AZN:LN USD 9.74B 495M
Baxter International BAX:US USD 6.57B 3.18B
Biogen BIIB:US USD 1.19B 1.45B
Bristol Myers Squibb BMY:US USD 9.46B 716M
Catalent CTLT:US USD 962M 105M
Coherus Biosciences CHRS:US USD 125.87M 21.71M
Drreddys Laboratories RDY:US INR 51.28B 4.35B
Eli Lilly And LLY:US USD 5.47B 200.3M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Gilead Sciences GILD:US USD 5.12B 917M
Glaxosmithkline GSK:US GBP 5.51B 1.13B
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Horizon Pharma HZNP:US USD 764.75M 23.1M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Medtronic MDT:US USD 6.18B 121M
Merk MRK:US USD 10.32B 624M
Novartis NVS:US USD 11.05B 378M
Novartis NOVN:VX USD 11.05B 378M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 19.12B 5.9B
Prestige Brands PBH:US USD 188.34M 16.55M
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Revance Therapeutics RVNC:US USD 106.5M 20.29M
Roche Holding ROG:VX 20.75B 3.26B
Teva Pharmaceutical Industries TEVA:US USD 3.18B 1.56B
United Therapeutics UTHR:US USD 201.7M 63.4M
Zoetis ZTS:US USD 1.34B 47M